1. Home/
  2. Compounds/
  3. decitabine:navitoclax (2:1 mol/mol)

decitabine:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2decitabine:navitoclax (2:1 mol/mol)
PharmacoGx decitabine:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to decitabine:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA MBTD1 CTRPv2 pan-cancer AAC 0.33 3e-19
mRNA ZBED4 CTRPv2 pan-cancer AAC 0.31 4e-18
mRNA GMFG CTRPv2 pan-cancer AAC 0.29 8e-12
mRNA WAS CTRPv2 pan-cancer AAC 0.28 1e-06
mRNA NCKAP1L CTRPv2 pan-cancer AAC 0.27 1e-09
mRNA YPEL1 CTRPv2 pan-cancer AAC 0.27 9e-17
mRNA SUGP2 CTRPv2 pan-cancer AAC 0.27 4e-13
mRNA ZNF8 CTRPv2 pan-cancer AAC 0.26 1e-14
mRNA SPN CTRPv2 pan-cancer AAC 0.26 2e-10
mRNA FEV CTRPv2 pan-cancer AAC 0.26 3e-10
Download CSV